Data Sheet | Click for Datasheet |
---|---|
Catalog Number | PA11221 |
Size | 100μl |
Host Type | Rabbit |
Immunogen | Synthetic peptide of human CLDN7 |
Specificity | Expressed in kidney, lung and prostate. Isoform 1 seems to be predominant, except in some normal prostate samples, where isoform 2 is the major form. Down-regulated in breast cancers, including ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS) and invasive ductal carcinoma (IDC) (at protein level), as well as in several cancer cell lines. Loss of expression correlates with histological grade, occurring predominantly in high-grade lesions. |
Isotype | IgG |
Reacitivity | Human,Mouse,Rat |
Clone | |
Uniprot | O95471 |
Concentration | 0.3 mg/mL |
Dilution | WB 1:1000-1:3000, IHC 1:50-1:150 |
Formulation | Application | WB,IHC,ELISA |
Other Names | CEPTR L2,CEPTRL 2,CEPTRL2,Claudin 1,Claudin 9,Claudin-7,Claudin1,Claudin7,Claudin9,CLD7,CLDN 7,CLDN-7,CLDN7,Clostridium perfringens enterotoxin receptor like 2,CPETR L2,CPETRL 2,CPETRL2,Hs.84359 |
Storage | Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C. |
Postscript | For research use only, not for use in diagnostic procedures. |
© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap